Table 1.
HCC patients (n = 150) | Univariate analysis of OS | Multivariate analysis of OS | Univariate analysis of DFS | Multivariate analysis of DFS | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
HR (log rank) | 95% CI | P-value | HR (log rank) | 95% CI | P-value | HR (log rank) | 95% CI | P-value | HR (log rank) | 95% CI | P-value | |
Age (years) ≥55/<55 | 0.926 | 0.630–1.362 | 0.695 | 1.268 | 0.791–2.034 | 0.609 | ||||||
Sex Male/female | 0.877 | 0.556–1.384 | 0.573 | 0.795 | 0.514–1.229 | 0.555 | ||||||
AFP (ng/ml) ≥7/<7 | 1.727 | 1.145–2.605 | 0.008* | 1.477 | 0.953–2.289 | 0.081 | 1.991 | 1.242–3.192 | 0.004* | 1.303 | 0.868–1.958 | 0.202 |
Staining score of KI67 ≥5%/<5% | 1.732 | 1.164–2.578 | 0.006* | 1.644 | 1.078–2.507 | 0.021* | 1.760 | 1.130–2.741 | 0.032* | 1.321 | 0.896–1.947 | 0.160 |
HBV Y/N | 1.429 | 0.876–2.329 | 0.150 | 1.768 | 1.092–2.862 | 0.143 | ||||||
Tumor size (cm) >3/≤3 | 1.545 | 1.018–2.345 | 0.039* | 1.358 | 0.860–2.144 | 0.189 | 2.489 | 1.528–4.056 | 0.014* | 1.146 | 0.737–1.782 | 0.544 |
Mavi Y/N | 4.238 | 2.391–7.511 | <0.001* | 1.556 | 0.565–4.282 | 0.392 | 1.519 | 0.780–2.956 | <0.001* | 1.558 | 0.613–3.957 | 0.351 |
Mivi Y/N | 1.634 | 1.105–2.418 | 0.013* | 1.412 | 0.946–2.107 | 0.091 | 0.940 | 0.606–1.459 | 0.025* | 1.487 | 1.027–2.152 | 0.036* |
Cirrhosis Y/N | 0.933 | 0.633–1.374 | 0.723 | 0.999 | 0.584–1.70- | 0.701 | ||||||
BCLC stage 0&A/B&C | 3.036 | 1.865–4.940 | <0.001* | 2.244 | 0.924–5.446 | 0.074 | 0.984 | 0.576–1.680 | <0.001* | 2.487 | 1.099–5.626 | 0.029* |
Staining score of PNO1 High/low | 2.098 | 1.419–3.103 | <0.001* | 1.703 | 1.111–2.609 | 0.014* | 0.535 | 0.316–0.906 | <0.001* | 2.421 | 1.605–3.651 | <0.001* |
Bold and asterisks are used to emphasize that the value is statistically significant.